GRIA4

Chr 11AD

glutamate ionotropic receptor AMPA type subunit 4

Also known as: GLUR4, GLUR4C, GLURD, GluA4, GluA4-ATD, NEDSGA

The protein is a subunit of AMPA-sensitive glutamate receptors that form ligand-gated ion channels mediating excitatory neurotransmission in the brain. De novo mutations cause autosomal dominant neurodevelopmental disorder with or without seizures and gait abnormalities. The pathogenic mechanism involves dominant-negative effects from the mutant protein.

OMIMResearchSummary from RefSeq, OMIM, UniProt, Mechanism
MultiplemechanismADLOEUF 0.431 OMIM phenotype
Clinical SummaryGRIA4
🧬
Gene-Disease Validity (ClinGen)
neurodevelopmental disorder with or without seizures and gait abnormalities · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.27) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint
0.43LOEUF
pLI 0.018
Z-score 4.70
OE 0.27 (0.170.43)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
3.42Z-score
OE missense 0.57 (0.510.63)
278 obs / 491.3 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.27 (0.170.43)
00.351.4
Missense OE0.57 (0.510.63)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 13 / 48.2Missense obs/exp: 278 / 491.3Syn Z: -0.47
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedGRIA4-related neurodevelopmental disorder with or without seizures and gait abnormalitiesOTHERAD
DN
0.81top 10%
GOF
0.79top 10%
LOF
0.2484th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GRIA4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →